ARCHIVES

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

This article is from The Cancer Letter archive.

Vol. 22 No. 20 | May 17, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010

Obit: Shirley Lansky, 66, Illinois Cancer Center Director, Dead.

November 30, 2001

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014